CI Financial (CIX) Q3 2024 earnings summary

Executive summary

• Achieved record adjusted diluted EPS of $0.97 and record adjusted EBITDA per share of $1.85, both up sequentially, driven by top-line growth, cost control, and lower share count, despite higher interest costs and non-recurring items impacting reported EPS.

• Total assets reached a record $518.1 billion at September 30, 2024, up 23% year-over-year and 6% sequentially, fueled by strong markets, net flows, and U.S. acquisitions.

• Free cash flow per share reached a record $1.32, with operating cash flow at $1.13–$1.14 per share.

• Strategic priorities include modernizing asset management, expanding wealth management, and globalizing operations.

• Net loss attributable to shareholders was $27.6 million for Q3 2024, compared to net income of $176.4 million in Q2 2024, due to non-cash adjustments.

Financial highlights

• Adjusted net income was $141.2 million, up from $132.8 million in Q3 2023 and $135.5 million in Q2 2024; adjusted EBITDA reached $270.5–$316.8 million with a 42.0% margin.

• Total net revenue for Q3 2024 was $754.9–$785.4 million, with U.S. acquisitions contributing to growth.

• Free cash flow for Q3 2024 was $192.3 million, up from $179.4 million in Q3 2023.

• Performance fee of $7 million ($0.04 per share) recognized from the asset management segment.

• Total expenses rose less than 1% year-over-year; SG&A decreased due to lower discretionary spending.

Outlook and guidance

• Interest and lease finance expenses expected to be $59–60 million in Q4; depreciation and amortization to rise to $19–20 million due to integration capex.

• Remaining Canadian wealth assets to be onboarded to custody platform within 10–12 months, with expected margin expansion.

• Continued focus on margin expansion in U.S. wealth segment post-integration, with further opportunities anticipated.

• IPO of Corient targeted for early to mid-2026, depending on market conditions.

• Management expects continued momentum, citing strong operating leverage and ongoing product innovation.